PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

ABSTRACT:

SUBMITTER: Shin J 

PROVIDER: S-EPMC10429756 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature